Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Goodwill 2022-2026 | MRNA

Annual FY2022–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$52.0M

0.0%flatYoY vs FY2024Source: 10-KFY2025

From $0 in FY2022 to $52.0M in FY2025.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$52M0.0%Not reportedNot reportedNot reported
FY25$52M0.0%$52M0.0%$52M0.0%$52M0.0%
FY24$52M0.0%$52M0.0%$52M0.0%$52M0.0%
FY23$52M$52M$52M$52M
FY22Not reportedNot reportedNot reported$0

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

N/A

FY2022
$0
FY2025
$52.0M

3 years selected · on the chart

Goodwill History

Year-over-year comparison from 10-K annual reports

  1. $52.0M
YoY changeLatest +0.0%

Goodwill, period by period

PeriodValueChangeSource
FY2025$52.0M0.0%flat10-K
FY2024$52.0M0.0%flat10-K
FY2023$52.0M—10-K
FY2022$0—10-K

What is goodwill?

Goodwill represents the premium paid above fair market value in business acquisitions, reflecting intangible value such as brand recognition and customer relationships.

What is Moderna, Inc.'s current goodwill?

Moderna, Inc. (MRNA) annual goodwill for 2025 was $52.0M, a 0.00% increase from 2024. Moderna, Inc. goodwill for the quarter ending March 31, 2026 was $52.0M.

What was Moderna, Inc.'s goodwill in 2024?

Moderna, Inc. annual goodwill for 2024 was $52.0M, a 0.00% increase from 2023.

What was Moderna, Inc.'s goodwill in 2023?

Moderna, Inc. annual goodwill for 2023 was $52.0M, a Infinity% increase from 2022.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)